Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Martinez Maria E, Director. Insider active across 1 company, notably Mirati Therapeutics, Inc.. In total, 4 reports have been published. History available since 14 January 2022. The latest transaction was filed on 29 December 2023 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Maria E. Martinez is a Director at Mirati Therapeutics, Inc. She participates in the governance of the company, bringing her expertise in biotechnology and strategy. Her role is essential for guiding strategic decisions.